Selected research
Industry Research
Coccidiosis Treatment Industry Research Report 2026
Market perspective
The global Coccidiosis Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Coccidiosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Coccidiosis Treatment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Coccidiosis Treatment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Coccidiosis Treatment include Zoetis, Inc., Novartis Animal Healthcare, Merck Animal Health, Bayer Animal Health, Virbac S.A., Vetoquinol S.A., Smartvet Inc., Jurox Pty Ltd. and Intas Pharmaceuticals Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Coccidiosis Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Coccidiosis Treatment Market by Company
Zoetis, Inc.
Novartis Animal Healthcare
Merck Animal Health
Bayer Animal Health
Virbac S.A.
Vetoquinol S.A.
Smartvet Inc.
Jurox Pty Ltd.
Intas Pharmaceuticals Ltd.
Huvepharma
Ceva Sante Animale
Boehringer Ingelheim Vetmedica, Inc.
Coccidiosis Treatment Segment by Type
Chemical Derivative Drugs
Antibiotic Drugs
Ionophore Drugs
Coccidiosis Treatment Segment by Application
Fish
Cattle
Poultry
Coccidiosis Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coccidiosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coccidiosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coccidiosis Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Coccidiosis Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Coccidiosis Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Coccidiosis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Derivative Drugs
- Antibiotic Drugs
- Ionophore Drugs
Applications
- Fish
- Cattle
- Poultry
Companies covered
- Zoetis, Inc.
- Novartis Animal Healthcare
- Merck Animal Health
- Bayer Animal Health
- Virbac S.A.
- Vetoquinol S.A.
- Smartvet Inc.
- Jurox Pty Ltd.
- Intas Pharmaceuticals Ltd.
- Huvepharma
- Ceva Sante Animale
- Boehringer Ingelheim Vetmedica, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Coccidiosis Treatment Market Size (2021-2032)
- 2.2.2 Global Coccidiosis Treatment Sales (2021-2032)
- 2.2.3 Global Coccidiosis Treatment Market Average Price (2021-2032)
- 2.3 Coccidiosis Treatment by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chemical Derivative Drugs
- 2.3.3 Antibiotic Drugs
- 2.3.4 Ionophore Drugs
- 2.4 Coccidiosis Treatment by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Fish
- 2.4.3 Cattle
- 2.4.4 Poultry
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Coccidiosis Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Coccidiosis Treatment Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Coccidiosis Treatment Revenue of Manufacturers (2021-2026)
- 3.4 Global Coccidiosis Treatment Average Price by Manufacturers (2021-2026)
- 3.5 Global Coccidiosis Treatment Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Coccidiosis Treatment, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Coccidiosis Treatment, Product Type & Application
- 3.8 Global Manufacturers of Coccidiosis Treatment, Established Date
- 3.9 Global Coccidiosis Treatment Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis, Inc.
- 4.1.1 Zoetis, Inc. Company Information
- 4.1.2 Zoetis, Inc. Business Overview
- 4.1.3 Zoetis, Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis, Inc. Coccidiosis Treatment Product Portfolio
- 4.1.5 Zoetis, Inc. Recent Developments
- 4.2 Novartis Animal Healthcare
- 4.2.1 Novartis Animal Healthcare Company Information
- 4.2.2 Novartis Animal Healthcare Business Overview
- 4.2.3 Novartis Animal Healthcare Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Animal Healthcare Coccidiosis Treatment Product Portfolio
- 4.2.5 Novartis Animal Healthcare Recent Developments
- 4.3 Merck Animal Health
- 4.3.1 Merck Animal Health Company Information
- 4.3.2 Merck Animal Health Business Overview
- 4.3.3 Merck Animal Health Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Animal Health Coccidiosis Treatment Product Portfolio
- 4.3.5 Merck Animal Health Recent Developments
- 4.4 Bayer Animal Health
- 4.4.1 Bayer Animal Health Company Information
- 4.4.2 Bayer Animal Health Business Overview
- 4.4.3 Bayer Animal Health Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer Animal Health Coccidiosis Treatment Product Portfolio
- 4.4.5 Bayer Animal Health Recent Developments
- 4.5 Virbac S.A.
- 4.5.1 Virbac S.A. Company Information
- 4.5.2 Virbac S.A. Business Overview
- 4.5.3 Virbac S.A. Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Virbac S.A. Coccidiosis Treatment Product Portfolio
- 4.5.5 Virbac S.A. Recent Developments
- 4.6 Vetoquinol S.A.
- 4.6.1 Vetoquinol S.A. Company Information
- 4.6.2 Vetoquinol S.A. Business Overview
- 4.6.3 Vetoquinol S.A. Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Vetoquinol S.A. Coccidiosis Treatment Product Portfolio
- 4.6.5 Vetoquinol S.A. Recent Developments
- 4.7 Smartvet Inc.
- 4.7.1 Smartvet Inc. Company Information
- 4.7.2 Smartvet Inc. Business Overview
- 4.7.3 Smartvet Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Smartvet Inc. Coccidiosis Treatment Product Portfolio
- 4.7.5 Smartvet Inc. Recent Developments
- 4.8 Jurox Pty Ltd.
- 4.8.1 Jurox Pty Ltd. Company Information
- 4.8.2 Jurox Pty Ltd. Business Overview
- 4.8.3 Jurox Pty Ltd. Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jurox Pty Ltd. Coccidiosis Treatment Product Portfolio
- 4.8.5 Jurox Pty Ltd. Recent Developments
- 4.9 Intas Pharmaceuticals Ltd.
- 4.9.1 Intas Pharmaceuticals Ltd. Company Information
- 4.9.2 Intas Pharmaceuticals Ltd. Business Overview
- 4.9.3 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product Portfolio
- 4.9.5 Intas Pharmaceuticals Ltd. Recent Developments
- 4.10 Huvepharma
- 4.10.1 Huvepharma Company Information
- 4.10.2 Huvepharma Business Overview
- 4.10.3 Huvepharma Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Huvepharma Coccidiosis Treatment Product Portfolio
- 4.10.5 Huvepharma Recent Developments
- 4.11 Ceva Sante Animale
- 4.11.1 Ceva Sante Animale Company Information
- 4.11.2 Ceva Sante Animale Business Overview
- 4.11.3 Ceva Sante Animale Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Ceva Sante Animale Coccidiosis Treatment Product Portfolio
- 4.11.5 Ceva Sante Animale Recent Developments
- 4.12 Boehringer Ingelheim Vetmedica, Inc.
- 4.12.1 Boehringer Ingelheim Vetmedica, Inc. Company Information
- 4.12.2 Boehringer Ingelheim Vetmedica, Inc. Business Overview
- 4.12.3 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product Portfolio
- 4.12.5 Boehringer Ingelheim Vetmedica, Inc. Recent Developments
5 Global Coccidiosis Treatment Market Scenario by Region
- 5.1 Global Coccidiosis Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Coccidiosis Treatment Sales by Region: 2021-2032
- 5.2.1 Global Coccidiosis Treatment Sales by Region: 2021-2026
- 5.2.2 Global Coccidiosis Treatment Sales by Region: 2027-2032
- 5.3 Global Coccidiosis Treatment Revenue by Region: 2021-2032
- 5.3.1 Global Coccidiosis Treatment Revenue by Region: 2021-2026
- 5.3.2 Global Coccidiosis Treatment Revenue by Region: 2027-2032
- 5.4 North America Coccidiosis Treatment Market Facts & Figures by Country
- 5.4.1 North America Coccidiosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Coccidiosis Treatment Sales by Country (2021-2032)
- 5.4.3 North America Coccidiosis Treatment Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Coccidiosis Treatment Market Facts & Figures by Country
- 5.5.1 Europe Coccidiosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Coccidiosis Treatment Sales by Country (2021-2032)
- 5.5.3 Europe Coccidiosis Treatment Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Coccidiosis Treatment Market Facts & Figures by Country
- 5.6.1 Asia Pacific Coccidiosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Coccidiosis Treatment Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Coccidiosis Treatment Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Coccidiosis Treatment Market Facts & Figures by Country
- 5.7.1 South America Coccidiosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Coccidiosis Treatment Sales by Country (2021-2032)
- 5.7.3 South America Coccidiosis Treatment Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Coccidiosis Treatment Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Coccidiosis Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Coccidiosis Treatment Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Coccidiosis Treatment Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Coccidiosis Treatment Sales by Type (2021-2032)
- 6.1.1 Global Coccidiosis Treatment Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Coccidiosis Treatment Sales Market Share by Type (2021-2032)
- 6.2 Global Coccidiosis Treatment Revenue by Type (2021-2032)
- 6.2.1 Global Coccidiosis Treatment Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Coccidiosis Treatment Revenue Market Share by Type (2021-2032)
- 6.3 Global Coccidiosis Treatment Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Coccidiosis Treatment Sales by Application (2021-2032)
- 7.1.1 Global Coccidiosis Treatment Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Coccidiosis Treatment Sales Market Share by Application (2021-2032)
- 7.2 Global Coccidiosis Treatment Revenue by Application (2021-2032)
- 7.2.1 Global Coccidiosis Treatment Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Coccidiosis Treatment Revenue Market Share by Application (2021-2032)
- 7.3 Global Coccidiosis Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Coccidiosis Treatment Value Chain Analysis
- 8.1.1 Coccidiosis Treatment Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Coccidiosis Treatment Production Mode & Process
- 8.2 Coccidiosis Treatment Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Coccidiosis Treatment Distributors
- 8.2.3 Coccidiosis Treatment Customers
9 Global Coccidiosis Treatment Analyzing Market Dynamics
- 9.1 Coccidiosis Treatment Industry Trends
- 9.2 Coccidiosis Treatment Industry Drivers
- 9.3 Coccidiosis Treatment Industry Opportunities and Challenges
- 9.4 Coccidiosis Treatment Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst